Table 4.
Peptide-graphene biosensors for detecting pathogens.
| Peptide sequence | Biosensor design | Interactions | Target | Biosensor type | Linear range | LOD | Ref. |
|---|---|---|---|---|---|---|---|
| SNAP-25 peptide | rGO | Pyrenebutyric acid linker | Botulinum neurotoxin A (BoNT/A) enzymatic activity | Electrochemistry | 1 pg/mL–1 ng/mL | 8.6 pg/mL | Chan et al. (2015) |
| GIGKFLHSAGKFGKAFVGEIMKS | holey rGO | EDC/NHS | E. coli O157:H7 | Electrochemistry | 104–107 CFU/mL | 803 CFU/mL | Chen et al. (2014) |
| KKNYSSSISSIHC | AgNPs-GO | Electrostatic interaction | LPS | Electrochemistry | 0.0005–1 EU/mL | 0.001 EU/mL | Yu et al. (2019) |
| KKNYSSSISSIHC | GO | Electrostatic interactions and/or π–π stacking | LPS | Fluorescence | 2 nM–10 μM | 130 pM | Lim et al. (2015) |
| RKRFRENLYFQSCP | GO | Electrostatic interaction | Tobacco etch virus (TEV) protease and engineered phage-infected bacteria | Fluorescence | TEV protease: 0–0.4 μg/μL bacteria: 103–107 CFU/mL | TEV protease: 51 ng/μL bacteria:104 CFU/mL | Chen and Nugen (2019) |
| SNAP-25 peptide | GO | EDC/NHS | Botulinum neurotoxin A (BoNT/A) enzymatic activity | Fluorescence | 1 fg/mL–1 pg/mL | 1 fg/mL | Shi et al. (2015) |
| RKRIHIGPGPAFYTT | GO | π–π stacking and hydrophobic interactions | HIV antibody | Fluorescence | 5–150 nM | 2 nM | Wu et al. (2014) |
| CALNNSQNYPIVQK | GO | EDC/NHS | HIV-1 protease | Fluorescence | 5–300 ng/mL | 1.18 ng/mL | Zhang et al. (2018) |
| RS5: RYWMS; QY7: QGYGYNY; ED17: EINPDSSTINYTPSLKD | GO | π–π stacking | Ebola virus (EBOV), Marburg virus (MARV), and Vesicular Stomatitis virus (VSV) | Fluorescence | EBOV: 0–15 ng/mL; MARV: 0–15 ng/mL; SV: 0–15 ng/mL | – | Fu et al. (2020) |
| GIGKFLHSAGKFGKAFVGEIMKS | AgNPs-rGO | Au–S bond | E. coli O157:H7 | Surface plasmon resonance | 1.0 × 103–5.0 × 107 CFU/mL | 5.0 × 102 CFU/mL | Zhou et al. (2018b) |
| Bacitracin A | Au@Ag-GO | EDC/NHS | E. coli, S. aureus and P. aeruginosa | Surface-enhanced Raman scattering | 101–106 CFU/mL | 101 CFU/mL | Yuan et al. (2018) |